Production (Stage)
Surgery Partners, Inc.
SGRY
$22.80
$0.200.89%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -32,333.33% | -1,312.61% | -76.68% | 37.87% | 100.65% |
| Total Depreciation and Amortization | 31.41% | 29.21% | 28.47% | 9.36% | -2.48% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 73.97% | 73.04% | 29.50% | 21.54% | -4.04% |
| Change in Net Operating Assets | -22.65% | -87.24% | -75.37% | 29.24% | 19.86% |
| Cash from Operations | 2.08% | 2.14% | 5.41% | 77.80% | 69.38% |
| Capital Expenditure | -7.72% | -1.80% | 4.14% | 3.88% | 1.38% |
| Sale of Property, Plant, and Equipment | -69.43% | -89.92% | -96.12% | -96.92% | -7.66% |
| Cash Acquisitions | -292.12% | -373.50% | -186.32% | -161.83% | 39.81% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 64.83% | 73.49% | 64.78% | 76.15% | 28.99% |
| Cash from Investing | -102.44% | -116.53% | -81.44% | -53.09% | 28.21% |
| Total Debt Issued | 74.52% | 109.25% | 659.09% | 803.62% | 352.30% |
| Total Debt Repaid | -40.27% | -58.51% | -103.79% | -103.37% | -5.87% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -21.71% | -7.84% | 3.02% | 4.96% | 12.60% |
| Cash from Financing | 416.52% | 268.81% | 105.33% | 184.70% | -284.53% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 173.13% | 184.60% | -117.49% | 172.20% | 54.80% |